【沃森生物:玉溪沃森mRNA疫苗获批上市许可,适用18周岁以上】沃森生物公告,玉溪沃森于2026年9月10日收到国家药品监督管理局批准颁发的新型冠状病毒mRNA疫苗《药品注册证书》,药品批准文号为国药准字S20260070,用于18周岁及以上人群预防新型冠状病毒感染引起的疾病。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.